About ThunderBio Innovation
ThunderBio Innovation is a company based in Jiaxing (China) founded in 2018 by Joseph Chow. ThunderBio Innovation has raised $15.47 million across 3 funding rounds from investors including Luxin Venture Capital, Zhuopu Investment and Guangzhou Financial Holdings. ThunderBio Innovation operates in a competitive market with competitors including Cepheid, ArcherDX, Beckman Coulter, Bruker and Blackrock Neurotech, among others.
- Headquarter Jiaxing, China
- Founders Joseph Chow
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.47 M (USD)
in 3 rounds
-
Latest Funding Round
$14.06 M (USD), Series B
Jan 02, 2024
-
Investors
Luxin Venture Capital
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ThunderBio Innovation
ThunderBio Innovation has successfully raised a total of $15.47M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $14.06 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ThunderBio Innovation
ThunderBio Innovation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Luxin Venture Capital, Zhuopu Investment and Guangzhou Financial Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bridgeone Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ThunderBio Innovation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ThunderBio Innovation
Investment portfolio details for ThunderBio Innovation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ThunderBio Innovation
Detailed financials for ThunderBio Innovation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thunderbio Innovation Comparisons
Peer comparison for ThunderBio Innovation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ThunderBio Innovation
ThunderBio Innovation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, ArcherDX, Beckman Coulter, Bruker and Blackrock Neurotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
Detailed competitors of ThunderBio Innovation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thunderbio Innovation
Complete news archive for ThunderBio Innovation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThunderBio Innovation
ThunderBio Innovation was founded in 2018 and raised its 1st funding round 2 years after it was founded.
ThunderBio Innovation is headquartered in Jiaxing, China. It is registered at Jiaxing, Zhejiang, China.
Joseph Chow is the current CEO of ThunderBio Innovation. They have also founded this company.
ThunderBio Innovation is a funded company, having raised a total of $15.47M across 3 funding rounds to date.
ThunderBio Innovation was founded in 2018 in Jiaxing, China, focusing on microfluidic technologies within the biotechnology sector. Operations center on the creation of lab-on-a-chip systems for digital liquid biopsy, alongside instruments such as digital PCR devices, biochip analyzers, droplet generators, and constant pressure pumps. Reagent kits, including those for digital PCR, nucleic acid extraction, and thermostatic amplification, are also produced to support diagnostic and research workflows.
ThunderBio Innovation's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.
ThunderBio Innovation has 10 investors. Key investors include Luxin Venture Capital, Zhuopu Investment, Guangzhou Financial Holdings, Daohe Technology Investment, and Shenzhen Chenmuyun Technology.